Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
26.46
-0.40 (-1.47%)
At close: Apr 28, 2026, 4:00 PM EDT
26.45
0.00 (-0.02%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Jade Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Jade Biosciences stock have an average target of 31.2, with a low estimate of 23 and a high estimate of 45. The average target predicts an increase of 17.94% from the current stock price of 26.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Jade Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $45 | Strong Buy | Maintains | $35 → $45 | +70.10% | Apr 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $35 | Strong Buy | Maintains | $25 → $35 | +32.30% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Maintains $28 → $39 | Strong Buy | Maintains | $28 → $39 | +47.42% | Mar 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $17 → $23 | Strong Buy | Maintains | $17 → $23 | -13.06% | Mar 11, 2026 |
| Wedbush | Wedbush | Buy Reiterates $24 | Buy | Reiterates | $24 | -9.28% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.12
from -3.19
EPS Next Year
-2.18
from -2.12
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.95 | -1.70 | |
| Avg | -2.12 | -2.18 | |
| Low | -2.30 | -2.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.